Table 2.
Liver ultrasound manifestations in HIV-positive and HIV-negative patients with/without chronic HCV or resolved HCV.
| Liver ultrasound manifestation | HIVneg chronic HCV | HIVpos chronic HCV | P a value | HIVneg resolved HCV | HIVpos resolved HCV | P b value |
|---|---|---|---|---|---|---|
| Total patients (n) | 102 | 76 | 56 | 48 | ||
|
| ||||||
| Echostructure | <0.001 | <0.001 | ||||
| Normal [n, (%)] | 73 (71.6%) | 24 (31.6%) | 40 (71.4%) | 16 (33.3%) | ||
| Altered echostructure [n, (%)] | 27 (26.5%) | 22 (28.9%) | 16 (28.6%) | 26 (54.2%) | ||
| Diffuse liver parenchyma lesions [n, (%)] | 2 (2.0%) | 30 (39.5%) | 0 | 6 (12.5%) | ||
| Others | ||||||
| Hepatomegaly [n, (%)] | 1 (1.0%) | 2 (2.6%) | 0.790 | 0 | 1 (2.1%) | 0.462 |
| Fatty liver [n, (%)] | 7 (6.9%) | 6 (7.9%) | 0.794 | 4 (7.1%) | 4 (8.3%) | 1.00 |
HCV: hepatitis C virus; HIV: human immunodeficiency virus; P a comparisons between HIV-negative and HIV-positive groups with chronic HCV infection; P b comparisons between HIV-negative and HIV-positive groups with resolved HCV.